Physician profile
Joanne Eure
NPI 1194940288
$1,520.41
in general payments reported to CMS, 2019-2025
16 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $381 · 2022: $60.55 · 2023: $478 · 2024: $374 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,078.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $475.66 | 2021-2025 | Belbuca, Xtampza |
| Braeburn INC. | $372.65 | 2023-2025 | Brixadi |
| Forte Bio-Pharma LLC | $132.73 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Indivior INC. | $96.56 | 2021-2025 | Sublocade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.46 | 2021-2025 | Relistor |
| Idorsia Pharmaceuticals US INC | $67.98 | 2023 | Quviviq |
| Scilex Pharmaceuticals INC. | $54.29 | 2021-2023 | Ztlido |
| Pfizer INC. | $52.72 | 2021 | |
| Abbott Laboratories | $39.67 | 2021 | |
| Valinor Pharma, LLC | $31.90 | 2024 | Movantik |
| Lilly USA, LLC | $28.30 | 2021 | |
| Virtus Pharmaceuticals LLC | $28.13 | 2023 | Levorphanol Tartrate |
| Vertex Pharmaceuticals Incorporated | $23.35 | 2024 | |
| Boston Scientific Corporation | $21.01 | 2022 | |
| Abbvie INC. | $12.71 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Eure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.